Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

April 10, 2020

Primary Completion Date

June 1, 2022

Study Completion Date

February 16, 2032

Conditions
Prostate AdenocarcinomaProstate CancerProstate Neoplasm
Interventions
RADIATION

Hypo-FLAME 2.0 study

SBRT technique with 35 Gy in 5 fractions to the whole prostate gland and an additional simultaneously integrated focal boost to the tumor nodule(s) visible on MRI up to 50 Gy (overall treatment time (OTT) = 15 days).

Trial Locations (3)

3000

University Hospitals Leuven, Leuven

1066 CX

The Netherlands Cancer Institute, Amsterdam

6525 GA

Radboudumc, Nijmegen

All Listed Sponsors
collaborator

The Netherlands Cancer Institute

OTHER

collaborator

Radboud University Medical Center

OTHER

collaborator

Kom Op Tegen Kanker

OTHER

lead

Universitaire Ziekenhuizen KU Leuven

OTHER